Jennifer Chow said: “These initial CLTX CAR T clinical data, while early, are highly encouraging as they demonstrate that CLTX CAR T cells are eliciting disease control in recurrent glioblastoma even at the lowest, sub-therapeutic dose level. Achieving disease control in 3 of the 4 patients treated at this first dose level, along with the generally well tolerated safety profile that was demonstrated, provides us with great enthusiasm for progressing the trial through the higher dose levels and dual routes of administration."
This is basically the CEO saying we have cured brain cancer.
- Forums
- ASX - By Stock
- Ann: CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA
Jennifer Chow said: “These initial CLTX CAR T clinical data,...
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $24.83M |
Open | High | Low | Value | Volume |
2.7¢ | 2.9¢ | 2.7¢ | $6.558K | 233.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 229266 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 69267 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 229266 | 0.028 |
7 | 1403547 | 0.027 |
6 | 754615 | 0.026 |
7 | 990000 | 0.025 |
10 | 1506666 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 69267 | 1 |
0.030 | 216203 | 2 |
0.031 | 483071 | 5 |
0.032 | 1550000 | 3 |
0.033 | 1273448 | 6 |
Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
2.8¢ |
  |
Change
0.002 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
2.8¢ | 2.8¢ | 2.8¢ | 40000 | ||
Last updated 14.24pm 07/05/2024 ? |
Featured News
CHM (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online